Related references
Note: Only part of the references are listed.Systemic Scleroderma-Definition, Clinical Picture and Laboratory Diagnostics
Anna Kowalska-Kepczynska
JOURNAL OF CLINICAL MEDICINE (2022)
Signals governing monocyte differentiation during inflammation
Susana L. Orozco et al.
CURRENT OPINION IN IMMUNOLOGY (2021)
Elevated Fibronectin Levels in Profibrotic CD14+ Monocytes and CD14+ Macrophages in Systemic Sclerosis
Michal Rudnik et al.
FRONTIERS IN IMMUNOLOGY (2021)
Human Monocyte Subset Distinctions and Function: Insights From Gene Expression Analysis
Sarah Cormican et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies
Yoshihide Asano
JOURNAL OF CLINICAL MEDICINE (2020)
Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts
Christopher W. Wasson et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease
Maebh Kelleher et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration
Yufei Xie et al.
DISEASE MODELS & MECHANISMS (2019)
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study
Barbara Ruaro et al.
RHEUMATOLOGY INTERNATIONAL (2019)
The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
Wen-Tao Ma et al.
FRONTIERS IN IMMUNOLOGY (2019)
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease
Satoshi Ebata et al.
JOURNAL OF DERMATOLOGY (2019)
More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages
Jan M. Ehrchen et al.
FRONTIERS IN IMMUNOLOGY (2019)
CEACAM1 structure and function in immunity and its therapeutic implications
Walter M. Kim et al.
SEMINARS IN IMMUNOLOGY (2019)
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis
Stefano Soldano et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression
Balsam Rizeq et al.
CANCER SCIENCE (2018)
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients
B. Ruaro et al.
MICROVASCULAR RESEARCH (2018)
Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial
Wieneke M. T. van den Hombergh et al.
TRIALS (2018)
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement
Amelia Chiara Trombetta et al.
RESPIRATORY RESEARCH (2018)
Identification of an atypical monocyte and committed progenitor involved in fibrosis
Takashi Satoh et al.
NATURE (2017)
Myeloid Populations in Systemic Autoimmune Diseases
Maria Morell et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Diverse oligomeric states of CEACAM IgV domains
Daniel A. Bonsor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma
X. Deng et al.
GENETICS AND MOLECULAR RESEARCH (2014)
Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors
Marzena Ciechomska et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Differentiation Potential of CD14+ Monocytes into Myofibroblasts in Patients with Systemic Sclerosis
Nadine Binai et al.
PLOS ONE (2012)
Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy
Jun Wei et al.
AUTOIMMUNITY REVIEWS (2011)
Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis
Nobuyo Higashi-Kuwata et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt
Dong Bai et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody
K. Komura et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2008)
Interdependency of CEACAM-1,-3,-6, and-8 induced human neutrophil adhesion to endothelial cells
Keith M. Skubitz et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I Interferons and Toll-like receptor agonists
Michael R. York et al.
ARTHRITIS AND RHEUMATISM (2007)
CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway
Qigui Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Novel mouse model for carcinoembryonic antigen-based therapy
CHF Chan et al.
MOLECULAR THERAPY (2004)
Share Paper
